Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Recruiting now · Not applicable

Conditions studied: Lung Cancer

In brief

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Key facts

Study ID

NCT05203328

Run by

The Cooper Health System

People needed

198

Starts

2022-02-01

Expected to finish

2026-05-01

Last updated by the study team

2025-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age>18 years
• patient undergoing EBUS bronchoscopy with moderate conscious sedation.

You may not qualify if…

• subjects with previous nasal surgeries
• subjects with oxygen saturation <90% on room air prior to procedure
• subjects who are pregnant
• subjects with known facial fractures or recent facial trauma
• subjects on any anticoagulation that cannot be discontinued prior to the procedure

Where it is running

• Cooper University Hospital — Camden, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.